Achieve More With Our Zepbound App
Track your Zepbound injections, side effects, and nutrition in one app. FDA-approved in 2023 specifically for weight management, Zepbound uses tirzepatide's dual GIP/GLP-1 action and carries different insurance coverage than Mounjaro. MeAgain tracks the full titration, and zero markup meds are $199/mo for eligible subscribers.
Last updated March 2026
What Features Does a Zepbound Tracking App Offer?
Zepbound-Specific Tracking for a Weight-Loss Indication
Zepbound received FDA approval for chronic weight management in 2023 — separate from Mounjaro's diabetes indication. MeAgain tracks Zepbound injections, dose, site, pain level, and notes with the weight-loss journey as the primary frame, not a secondary use case.
Shot Day Checklist Across the Full Titration
Zepbound's titration runs from 2.5mg through 15mg in 2.5mg increments — with side effects often strongest during dose increases. The shot day checklist walks through every prep step at each level, and the 7-day estimated tirzepatide levels chart shows where you are between injections.
Progress Tracking Built for Zepbound's Weight Loss Timeline
Zepbound's weight-loss results accumulate over months, not weeks. Journey Cards record photo-based milestones, weight trend charts show the trajectory from starting dose to maintenance, and the Capybara widget tracks daily protein, water, fiber, and steps in real time on your home screen.
Understanding Your Zepbound App: Tirzepatide for Weight Loss
Zepbound is the brand name for tirzepatide, FDA-approved specifically for chronic weight management. It uses the same active ingredient as Mounjaro but is indicated for weight loss rather than type 2 diabetes.
| Feature | Zepbound | Mounjaro |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| FDA indication | Weight management | Type 2 diabetes |
| Available doses | 2.5mg to 15mg | 2.5mg to 15mg |
| Insurance coverage | Weight loss plans | Diabetes plans |
| Pen design | Identical | Identical |
What to Expect During Zepbound Titration
- Start at 2.5mg for at least 4 weeks
- Increase in 2.5mg increments
- Your provider determines the pace of increases
- Most people reach a maintenance dose between 5mg and 15mg
- Side effects are typically strongest during dose increases
Zepbound and Mounjaro are the same molecule — tirzepatide. MeAgain tracks both identically. If you switch between them, your injection history and estimated medication levels stay consistent.
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your medication.
How Can You Visualize Your Zepbound Progress?
Track Zepbound Results as a Weight-Loss Journey
Zepbound is FDA-approved specifically for weight management — and MeAgain frames the entire tracking experience around that goal. Weight trend charts show your trajectory from starting dose, Journey Cards capture milestone moments, and the Capybara widget keeps the daily habit in view on your home screen.
Side Effect Tracking Tied to Dose Increases
Zepbound's titration side effects — nausea, fatigue, constipation, food noise — are typically most pronounced in the weeks following a dose increase. Log each with a severity slider and custom symptoms so you can see the pattern of when tirzepatide's adjustment period is easing at each new level.
A Log That Reflects Zepbound's Insurance Complexity
Zepbound's coverage differs from Mounjaro's even though they share the same molecule — it's covered under weight-loss benefit riders, not diabetes plans. MeAgain keeps your complete injection and progress history so your health partner has the documentation needed for coverage conversations.
What Are Real Zepbound Users Saying?
Connect With Fellow Users
Zepbound is newer to the market than Mounjaro — approved in late 2023 for weight management — and many subscribers are navigating the insurance, access, and titration learning curve for the first time. MeAgain gives Zepbound users a complete tracking tool built around the weight-loss journey, not retrofitted from a diabetes app.
Over 286,000 people are on their GLP-1 journey with MeAgain — including subscribers who started on Mounjaro and switched to Zepbound for the weight-loss indication. For eligible subscribers, zero markup compounded tirzepatide is available in-app at $199/mo with no commitments.
What Our Users Say
Learn More About Zepbound
13 Foundayo Side Effects and How to Stay Consistent on Treatment
Learn 13 Foundayo side effects and practical tips to manage them while staying consistent on treatment and maintaining results.
Are Foundayo and Orforglipron Different? Here’s the Truth
Foundayo vs Orforglipron: The main differences explained. Learn how these treatments compare in use, effects, and key distinctions.
Which Is Better: Foundayo or Oral Wegovy? Full Comparison (2026)
Which is better: Foundayo or Oral Wegovy? Compare effectiveness, cost, safety, and results to choose the right weight-loss option.
How Is Foundayo Different From Zepbound? Complete GLP-1 Guide
How Is Foundayo Different From Zepbound? Compare benefits, side effects, and key differences in this complete GLP-1 guide.
Zepbound App - Your Questions Answered
MeAgain is the all-in-one app built for the GLP-1 experience — including Zepbound, which received FDA approval for chronic weight management in 2023. It tracks tirzepatide injections, estimated medication levels, nutrition, side effects, and weight, with a shot day prep checklist and the Capybara home screen widget. A free tier is included to get started.
Related Pages
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.